高级搜索
腺病毒介导的siRNA下调c-Met表达抑制肝癌细胞生长[J]. 肿瘤防治研究, 2008, 35(05): 309-312. DOI: 10.3971/j.issn.1000-8578.2852
引用本文: 腺病毒介导的siRNA下调c-Met表达抑制肝癌细胞生长[J]. 肿瘤防治研究, 2008, 35(05): 309-312. DOI: 10.3971/j.issn.1000-8578.2852
Inhibitory Effects of Knockdown of c-Met by Adenovirus-delivered siRNA on Growth of Hepatocellular Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2008, 35(05): 309-312. DOI: 10.3971/j.issn.1000-8578.2852
Citation: Inhibitory Effects of Knockdown of c-Met by Adenovirus-delivered siRNA on Growth of Hepatocellular Carcinoma Cells[J]. Cancer Research on Prevention and Treatment, 2008, 35(05): 309-312. DOI: 10.3971/j.issn.1000-8578.2852

腺病毒介导的siRNA下调c-Met表达抑制肝癌细胞生长

Inhibitory Effects of Knockdown of c-Met by Adenovirus-delivered siRNA on Growth of Hepatocellular Carcinoma Cells

  • 摘要: 目的 探讨重组腺病毒介导的siRNA技术下调c-Met表达对c-Met过表达肝癌细胞在体外生长和成瘤性的影响。方法 用重组腺病毒介导的siRNA技术下调c-Met的表达;通过Western blot检测蛋白质的表达水平;以MTT法和细胞计数法检测细胞的生长和增殖情况;以流式细胞术检测细胞周期变化情况;以软琼脂克隆形成实验考察细胞的克隆形成能力。结果 重组腺病毒介导的siRNA可使HCCLM3细胞c-Met的表达量下调90%以上。下调c-Met表达可使HCCLM3细胞生长停留在G1/G0期,增殖速率下降30%以上;下调c-Met表达可使HCCLM3细胞克隆形成能力下降约78%(P<0.01)。结论 重组腺病毒介导的siRNA下调c-Met表达具潜在的肝癌基因治疗价值。

     

    Abstract: Objective  To investigate the effect s of knockdown of c2Met by adenovirus2delivered siRNA on the growth of hepatocellular carcinoma cells in vit ro. Methods  c2Met was knocked down by adenovirus2 delivered siRNA. The expression of protein was detected by Western blot . Cell proliferation was deter2 mined by MTT assay and Cell count experiment s. Cell cycle was analyzed by flow cytomet ry. Cell colony formation ability was assessed by sof t agar colony formation assay. Results  The adenovirus2delivered siRNA could decrease the c2Met expression of HCCLM3 cells by over 90 %. Knockdown of c2Met could arrest HCCLM3 cells at G1 / G0 and inhibit the proliferation of HCCLM3 cells by over 30 %( P < 0. 01) . Furthermore, Knockdown of c2Met could reduce HCCLM3 cells colony formation by 78 % ( P < 0. 01) . Conclusion  Knockdown of c2Met expression by adenovirus2delivered siRNA may be a potential approach for hepatocellular carcinoma gene therapy.

     

/

返回文章
返回